Healthcare Realty Trust (NYSE:HR) Posts Earnings Results, Beats Expectations By $0.01 EPS

Healthcare Realty Trust (NYSE:HRGet Free Report) posted its earnings results on Wednesday. The real estate investment trust reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01, Zacks reports. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. The company had revenue of $309.77 million during the quarter, compared to the consensus estimate of $303.81 million. During the same period in the previous year, the firm posted $0.39 earnings per share. The firm’s quarterly revenue was down 6.3% on a year-over-year basis. Healthcare Realty Trust updated its FY 2025 guidance to 1.560-1.600 EPS and its FY25 guidance to $1.56 to $1.60 EPS.

Healthcare Realty Trust Trading Down 0.4 %

HR stock opened at $16.71 on Thursday. The firm has a 50-day moving average of $16.68 and a two-hundred day moving average of $17.42. The company has a market cap of $5.92 billion, a price-to-earnings ratio of -10.56 and a beta of 0.94. Healthcare Realty Trust has a 12 month low of $12.77 and a 12 month high of $18.90.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on HR shares. JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target on the stock. in a report on Friday, December 20th. Wedbush lowered shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $18.00 to $16.00 in a report on Thursday, January 2nd. Finally, Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and lowered their target price for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Two investment analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $17.00.

Read Our Latest Stock Analysis on Healthcare Realty Trust

Insider Transactions at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian acquired 7,750 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was purchased at an average price of $17.39 per share, with a total value of $134,772.50. Following the transaction, the director now owns 50,002 shares of the company’s stock, valued at approximately $869,534.78. This trade represents a 18.34 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Peter F. Sr Lyle, Sr. purchased 10,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $17.21 per share, with a total value of $172,100.00. Following the transaction, the director now directly owns 26,576 shares in the company, valued at $457,372.96. This trade represents a 60.33 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 18,750 shares of company stock worth $323,723 in the last 90 days. Insiders own 0.56% of the company’s stock.

Healthcare Realty Trust Company Profile

(Get Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Recommended Stories

Earnings History for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.